Technical Program | AIChE

Technical Program

Saturday October 28th  ...

Saturday October 28th 


7:30 AM - 12:00 PM Registration
8:45 AM - 9:00 AM Welcome Remarks
9:00 AM - 11:30 AM Session 1: Stem Cells
  Chair: Wei Shen, University of Minnesota  
9:00 AM - 9:30 AM Invited Speaker: "Stem Cell Aging and Reprogramming: Implications for Regenerative Medicine" — Stelios Andreadis, University at Buffalo, SUNY  
9:30 AM - 9:45 AM "Atomistic Simulations for Construction of an “in Vitro - In Vivo - Ex Vivo – in Cyto - in silico” Performance-Correlation Profile within Biomedical Material Assemblies." — Pradeep Kumar, University of the Witwatersrand
9:45 AM - 10:00 AM "Cortical Spheroid Development Tracked with a Novel Imaging Platform (DNA-PRISM) Reveals Culture Complexity and Establishes Reproducible Phenotype Baseline for Compound Screens and Disease Modeling." Martin L Tomov, Broad Institute, Cambridge
10:00 AM - 10:15 AM "Engineering the Liver Diverticulum from Human Pluripotent Stem Cells." —

Ogechi Ogoke, University at Buffalo, SUNY
10:15 AM - 10:45 AM Break
10:45 AM - 11:00 AM "Formation of Adipose Stromal Vascular Fraction Cell Laden Spheroids Using a 3D Bioprinter and Superhydrophobic Surfaces." — Piyani Gandhi, University of Louisville
11:00 AM - 11:15 AM "Scalable Production of Human Cardiac Tissues through hiPSC Encapsulation in Gelatin Methacryloyl" — Morgan Ellis, Auburn University
11:15 AM - 11:30 AM "Encapsulation of Mesenchymal Stem Cells in GAG-Chitosan Polyelectrolyte Microcapsules Using a Novel Electrospraying Technique: Investigating Capsule Morphology and Cell Viability." — Amin Vossoughi Shahvari, Wayne State University
11:30 AM - 1:00 PM Lunch
1:00 PM - 3:15 PM Session 2: Immunoengineering
  Chair: Fei Wen, University of Michigan     
1:00 PM - 1:30 PM Invited Speaker: "Vignettes on Engineering Targeted, Immunomodulatory Therapies"— Michael Look, Pfizer    
1:30 PM - 1:45 PM "Inhibition of Cancer Immune Suppression with a First-in-Class Engineered Therapeutic Enzyme." — John Blazeck ,University of Texas at Austin, Austin
1:45 PM - 2:00 PM "Engineering Robust T Cells for Cancer Immunotherapy." — Yvonne Y. Chen, University of California, Los Angeles
2:00 PM - 2:15 PM "Quantitative In Vivo & Ex Vivo Multimodality Cell Imaging of Antigen-Specific T-Cells in Murine Metastatic Ovarian Cancer." — Matthew Willadsen, University at Buffalo, SUNY
2:15 PM - 2:30 PM "Single-Cell Profiling Demonstrates That Migratory T Cells Demonstrate Superior Persistence and Enhanced Tumor Control." — Navin Varadarajan, University of Houston
2:30 PM - 2:45 PM "Engineering Nanotechnologies for Immuno-Oncology: "Smart" Nanoparticles for Immunotherapeutic Targeting of the Sting Pathway." — John Wilson, Vanderbilt University
2:45 PM - 3:00 PM "Direct Selection of Synthetic Binding Proteins That Recognize Post-Translationally Modified Proteins in Living Cells." — Bunyarit Meksiriporn, Cornell University
3:00 PM - 3:15 PM "Utilizing Oxygen-Inhibited Photopolymerization to Control Size of Multimodal PEGDA Hydrogel Nanoparticles for Cancer Therapeutics."— Daniel Debroy, University of Wyoming
3:15 PM - 3:45 PM Break
3:45 PM - 6:30 PM Session 3:  Translation (VC, IP, regulatory, business)
  Chair: Yiannis Kaznessis, University of Minnesota  
3:45 PM - 4:15 PM Invited Speaker: "3D Printing Functional Materials & Devices for Biomanufacturing." — Michael McAlpine, University of Minnesota  
4:15 PM - 4:30 PM “Accelerated Development Pathways for Biopharmaceuticals – Will Your CMC Package Be Submission Ready?” — Arindam Bose, AbiologicsB, LLC
4:30 PM - 4:45 PM "Commercial considerations in the development of therapy-enabling technologies" — Paul Burke, Burke Bioventures
4:45 PM - 5:00 PM "How will the field of gene therapy survive its success?" — Bill Kaemmerer, CGTA Research Group
5:00 PM - 5:15 PM "Translation of viral and non-viral gene transfer for metabolic disease" — Scott McIvor, University of Minnesota, Discovery Genomics Inc., Immunosoft Corp.
5:15 PM - 5:30 PM "Translational Research in a University Setting: Too many “local” hurdles and how to avoid them" — Nicholas Peppas, The University of Texas at Austin
5:30 PM - 5:45 PM "Translating Big Ideas into Novel Therapies…from Science to Entrepreneurial Startups" — John Santini, Vergent Bioscience
5:45 PM - 6:30 PM Discussion
6:30 PM - 7:30 PM Poster Session

Sunday October 29th

8:30 AM - 9:30 AM Registration
9:30 AM - 11:15 AM Session 4: Biopharmaceuticals
  Chair: Honggang Cui, Johns Hopkins University   
9:30 AM - 10:00 AM Invited Speaker:" Role of Folate-Dependent One-Carbon Metabolism and Transulfuration Pathways in Autism Spectrum Disorder"— Juergen Hahn, Rensselaer Polytechnic Institute    
10:00 AM - 10:15 AM "Site-Directed Polymer-Drug Complexes for Modulating Gut Innate Immune System to Prevent/Treat Inflammatory Bowel Diseases (IBD)." — Siddharth Kesharwani, South Dakota State University
10:15 AM - 10:30 AM "Lipid-Polymer Hybrid Nanoparticles Incorporating Diverse HIV-1 Cure Agents for Latency Reversal." — Shijie Cao. University of Washington
10:30 AM - 10:45 AM Break
10:45 AM - 11:00 AM "FRET-Based High-Throughput Screening of Small-Molecule Inhibitors of TNF Receptors." — Chih Hung Lo, University of Minnesota
11:00 AM - 11:15 AM "Interfacial Curvature Effects on Morphology and Dynamics of Monolayer Membrane." —Amit Kumar Sachan, University of Minnesota
11:15 AM - 11:30 AM "Microbial Delivery of Antimicrobial Peptides for Protection Against Multidrug-Resistant Pathogens." — Yiannis Kaznessis University of Minnesota
11:30 AM - 1:00 PM Lunch
1:00 PM - 3:00 PM Session 5: Gene and Drug Delivery
  Chair: Katie Whitehead, Carnegie Mellon University  
1:00 PM - 1:30 PM Invited Speaker: "Systemic, Targeted Nanotherapies for the Treatment of Neuroinflammation in CNS Disorders: From Chemistry to Clinical Translation"—  Rangamanujam Kannan, Johns Hopkins University  
1:30 PM - 1:45 PM "Effect of Alkylation on the Cellular Uptake of Polyethylene Glycol-Coated Gold Nanoparticles." — Chung Hang Jonathan Choi,  The Chinese University of Hong Kong
1:45 PM - 2:00 PM  "Self-Assembling Prodrugs" — Honggang Cui, Johns Hopkins University
2:00 PM - 2:15 PM "Enhancing Therapeutic Efficacy of Self-Assembling Prodrugs with Supramolecular Chemistry" — Hao Su, Johns Hopkins University
2:15 PM - 2:30 PM "Microfluidics: Accelerating Nanomedicine Research and Development" — Andrea Armstead, Precision Nanosystems
2:30 PM - 2:45 PM "Topical Drug Delivery to Skin Using STAR Particles" — Mark R. Prausnitz  Georgia Institute of Technology
2:45 PM - 3:00 PM "Intracellular and Extracellular Delivery of Protein and Small Biomolecules Via Near-Infrared Light." — JeongEun Shin, University of Minnesota
3:00 PM - 3:30 PM Break
3:30 PM - 4:45 PM Session 5: Gene and Drug Delivery Continued
  Chair: Samira Azarin, University of Minnesota   
3:30 PM - 3:45 PM "Fine-Tuning the Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels" — Rami Chakroun,  Johns Hopkins University
3:45 PM - 4:00 PM "Metal Ion Triggered Assembly of Peptide-Drug Conjugates" —

Han Wang, Johns Hopkins University
4:00 PM - 4:15 PM "Cartilage Penetrating Nanocarriers to Provide Sustained Delivery of Disease Modifying Drugs in Post-Traumatic Osteoarthritis" — Brett C Geiger  Massachusetts Institute of Technoloy
4:15 PM - 4:30 PM "Investigating the Impact of the Surface Properties of Intravitreally Injected Carriers on Their Retinal Bio-Distribution in a Single Nanoplatform." — Xiaonan Huang The Hong Kong University of Science and Technology
4:30 PM - 4:45 PM "Rapid, Room-Temperature Nanoparticle Drying and Low Energy Reconstitution Via Electrospinning." — Shani Levit, Virginia Commonwealth University 
4:45 PM - 5:00 PM Closing Remarks